Long-term outcomes and adaptive behavior in adult patients with Lennox-Gastaut syndrome

被引:1
作者
Irelli, Emanuele Cerulli [1 ]
Petrungaro, Alessio [2 ]
Pastorino, Grazia M. G. [3 ]
Mazzeo, Adolfo [4 ]
Morano, Alessandra [1 ]
Casciato, Sara [5 ]
Salati, Emanuela [1 ]
Operto, Francesca F. [6 ]
Giallonardo, Anna T. [1 ]
Di Gennaro, Giancarlo [4 ]
Di Bonaventura, Carlo [1 ]
机构
[1] Sapienza Univ, Dept Human Neurosci, Viale Univ 30, I-00185 Rome, Italy
[2] Don Carlo Gnocchi Fdn, Neurorehabil Unit, IRCCS Santa Maria Nascente, Milan, Italy
[3] Univ Salerno, Dept Med Surg & Dent, Child & Adolescent Neuropsychiat Unit, Salerno, Italy
[4] IRCCS Neuromed, Pozzilli, Italy
[5] S Camillo Forlanini Hosp, Dept Neurosci, Rome, Italy
[6] Magna Graecia Univ Catanzaro, Sch Med, Sci Hlth Dept, Catanzaro, Italy
关键词
cannabidiol; cognitive; electroencephalography; neuropsychological; prognosis; Vineland Adaptive Behavior Scale; CONSENSUS APPROACH; DEFINITION; MANAGEMENT; PROGNOSIS;
D O I
10.1002/epi4.13024
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveLennox-Gastaut syndrome (LGS) is a severe form of epilepsy characterized by difficult-to-control seizures and cognitive dysfunction. Previous studies mainly focused on pediatric populations, and little is known about the long-term cognitive outcome in adult patients with LGS. The objective of this study was to investigate the long-term functional and adaptive behavior in adult patients with LGS.MethodsThis cross-sectional study enrolled adult patients diagnosed with LGS according to the recently published International League Against Epilepsy (ILAE) diagnostic criteria. The adaptive behavior of participants was assessed using the Vineland Adaptive Behavior Scales, Survey Interview, Second Edition (VABS-II). Demographic, clinical, electroencephalography (EEG), and antiseizure medication (ASM) data were also collected at different timepoints, to investigate their association with VABS-II scores.ResultsThe study included 38 adult patients with LGS. A low score on the Adaptive Behavior Composite Scale was found in all patients. When considering single VABS-II domains, particularly low scores were found in daily living skills and socialization, whereas slightly higher performances were observed in communication. An earlier age at LGS diagnosis was identified as the most significant predictor of worse adaptive outcomes in adult life. At the time of study evaluation, high seizure frequency, higher EEG background slowing, and multifocal EEG epileptiform abnormalities were significantly associated with lower VABS-II raw scores. Furthermore, in an exploratory correlation analysis with ASM regimen at the study visit, treatment with cannabidiol was associated with higher adaptive behavior scores, whereas benzodiazepine intake correlated with lower scores.SignificanceThis study provides relevant insights into the long-term challenges faced by adults with Lennox-Gastaut syndrome (LGS), highlighting significant impairments in adaptive behavior as well as the associated clinical and electroencephalography features. Additionally, this study provides a more specific neuropsychological profile in adults with LGS and underscores the importance of comprehensive care approaches that go beyond seizure control in this population.Plain Language SummaryThis study examined adults with Lennox-Gastaut syndrome (LGS), a severe type of epilepsy, to understand their long-term abilities to perform daily tasks and adapt socially. We found that these adults have significant difficulties with daily living and social skills, although not all areas were equally affected. They performed somewhat better in communication, particularly in understanding others (receptive communication). Importantly, the younger the age at which LGS was diagnosed, the worse their outcomes were as adults. This study highlights the need for research and treatment approaches that focus not only on controlling seizures but also on improving daily life skills.
引用
收藏
页码:1881 / 1890
页数:10
相关论文
共 31 条
  • [11] Frailty as a comprehensive health measure beyond seizure control in patients with epilepsy: A cross-sectional study
    Irelli, Emanuele Cerulli
    Borioni, Maria S.
    Morano, Alessandra
    Mazzeo, Adolfo
    Moro, Pierludovico
    Orlando, Biagio
    Salamone, Enrico M.
    Giordano, Luca
    Petrungaro, Alessio
    Blasi, Marco Toccaceli
    Giallonardo, Anna T.
    Canevelli, Marco
    Di Bonaventura, Carlo
    [J]. EPILEPSIA, 2024, 65 (06) : 1658 - 1667
  • [12] Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
    Kwan, Patrick
    Arzimanoglou, Alexis
    Berg, Anne T.
    Brodie, Martin J.
    Hauser, W. Allen
    Mathern, Gary
    Moshe, Solomon L.
    Perucca, Emilio
    Wiebe, Samuel
    French, Jacqueline
    [J]. EPILEPSIA, 2010, 51 (06) : 1069 - 1077
  • [13] Marchese F., 2021, SN Comprehensive Clinical Medicine, V3, P2167, DOI [10.1007/s42399-021-00989-y, DOI 10.1007/S42399-021-00989-Y]
  • [14] Lennox-Gastaut syndrome (Childhood epileptic encephalopathy)
    Markand, ON
    [J]. JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2003, 20 (06) : 426 - 441
  • [15] Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
    Metternich, Birgitta
    Wagner, Kathrin
    Geiger, Maximilian J.
    Hirsch, Martin
    Schulze-Bonhage, Andreas
    Klotz, Kerstin A.
    [J]. EPILEPSY & BEHAVIOR, 2021, 114
  • [16] Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients
    Montouris, Georgia
    Aboumatar, Sami
    Burdette, David
    Kothare, Sanjeev
    Kuzniecky, Ruben
    Rosenfeld, William
    Chung, Steve
    [J]. EPILEPSY & BEHAVIOR, 2020, 110
  • [17] OPEN STUDY OF CLOBAZAM IN REFRACTORY EPILEPSY
    MUNN, R
    FARRELL, K
    [J]. PEDIATRIC NEUROLOGY, 1993, 9 (06) : 465 - 469
  • [18] Long-term prognosis of Lennox-Gastaut syndrome
    Oguni, H
    Hayashi, K
    Osawa, M
    [J]. EPILEPSIA, 1996, 37 : 44 - 47
  • [19] OHTSUKA Y, 1990, JPN J PSYCHIAT NEUR, V44, P257
  • [20] Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study
    Operto, Francesca Felicia
    Verrotti, Alberto
    Marrelli, Alfonso
    Ciuffini, Roberta
    Coppola, Giangennaro
    Pastorino, Grazia Maria Giovanna
    Striano, Pasquale
    Sole, Michela
    Zucca, Claudio
    Manfredi, Valentina
    Citta, Santina
    Elia, Maurizio
    [J]. EPILEPSY & BEHAVIOR, 2020, 112